![](/img/cover-not-exists.png)
Abstracts: 12th Annual Conference of the International Society for Quality of Life Research (ISOQOL) || P-305/1207/Does Epidermal Growth Factor Receptor Inhibitor (EGFRI) Skin Toxicity Affect Qol? Results from a National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) Rct
H. J. Au, D. Goldstein, K. Ding, W. Parulekar, S. Gallinger and M. MooreVolume:
14
Language:
english
Journal:
Quality of Life Research
DOI:
10.2307/4039829
Date:
November, 2005
File:
PDF, 329 KB
english, 2005